Funded Startups in Lyon
Across Lyon’s 50 most recent funded startups, the largest disclosed round is MaaT Pharma’s $44M on 2025-07-28, which is in the same overall magnitude as Os…
Across Lyon’s 50 most recent funded startups, the largest disclosed round is MaaT Pharma’s $44M on 2025-07-28, which is in the same overall magnitude as Osivax’s $20M (2025-08-26) and Fab’entech’s $22M (2024-10-07), but it stands far above the large majority of disclosed rounds that cluster closer to the low-to-mid single-digit million range (e.g., Ventuno Biotech $2M on 2025-11-24 and ENYO Pharma $7M on 2025-06-12). Date-wise, funding appears to concentrate in back-to-back periods: five of the 2024 entries run between May and July 2024 (from Vizcab $5M on 2024-05-28 through Ubikap $1M on 2024-07-16), while the newest stretch is unusually dense in 2025 with multiple rounds from February–August 2025 (e.g., Wavo $4M on 2025-02-18, NETRI $5M on 2025-02-02, Adocia $10M on 2025-02-26, and Osivax $20M on 2025-08-26). The list is also heavily biotech-tilted (notably Ventuno Biotech 2025-11-24 at $2M through multiple 2023–2024 biotech financings), and multiple lines have amounts marked “undisclosed” (Bon Vivant 2024-06-11; UNITe 2024-06-11; WeTransact 2023-05-09; Cosmo Tech 2024-12-02), which creates a reporting outlier alongside the smallest disclosed amount: $10K for Havah on 2023-11-04.
Most recent rounds
50 shownRelated listings
Frequently asked
Which company has the largest disclosed round in the Lyon list, and how does it compare with the rest of the disclosed amounts?
MaaT Pharma’s $44M on 2025-07-28 is the largest disclosed amount in the 50 rows, and it sits well above the next-largest disclosed figures shown (e.g., Fab’entech $22M on 2024-10-07 and Osivax $20M on 2025-08-26), while many other disclosed rounds are in the $1M–$10M band (such as Ventuno Biotech $2M on 2025-11-24 and ENYO Pharma $7M on 2025-06-12).
Is there a time window where more rounds cluster, especially near the newest dates?
Yes: 2025 shows a tight concentration between early February and late August 2025, including NETRI $5M (2025-02-02), Wavo $4M (2025-02-18), Adocia $10M (2025-02-26), ENYO Pharma $7M (2025-06-12), MaaT Pharma $44M (2025-07-28), and Osivax $20M (2025-08-26). In 2024, another grouping spans May–July 2024 (Vizcab $5M on 2024-05-28, Fluid Topics $16M on 2024-04-05, and Ubikap $1M on 2024-07-16 are separated but sit within the same mid-year window).
How dominant is biotech in this Lyon set compared with other sectors?
Biotechnology appears repeatedly across both 2025 and 2023–2024 (e.g., Ventuno Biotech $2M on 2025-11-24, MaaT Pharma $44M on 2025-07-28, Osivax $20M on 2025-08-26, and Lys Therapeutics $600K on 2023-03-15), indicating a biotech-heavy mix relative to sectors that show up only once or twice (for example, Real Estate has Clovis $2M on 2025-01-28 and Vizcab $5M on 2024-05-28).
Do undisclosed amounts create meaningful outliers versus the disclosed range?
Undisclosed amounts occur alongside disclosed financing, including Cosmo Tech (2024-12-02, amount undisclosed), Bon Vivant (2024-06-11, amount undisclosed), UNITe (2024-06-11, amount undisclosed), and WeTransact (2023-05-09, amount undisclosed), which prevents direct sizing comparisons for those rounds. Separately, the smallest disclosed amount is Havah’s $10K on 2023-11-04, providing a low-end magnitude outlier even when ignoring the undisclosed rows.
Which stage labels show up most often, and are there notable high-stage financed rounds?
Multiple rounds are labeled “Series Unknown” (e.g., Osivax 2025-08-26 at $20M and MaaT Pharma 2025-07-28 at $44M are both Series Unknown, along with Adocia 2025-02-26 at $10M and Allogenica 2025-03-19 at $3M), so the stage mix is frequently unspecified. High disclosed sizes also appear in later labels: Indy is “Series C” at $44M on 2023-11-20, while Dougs Compta’s “Series A” is $27M on 2023-07-05.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.